Respiratory microbiota: addressing clinical questions, informing clinical practice
Over the last decade, technological advances have revolutionised efforts to understand the
role played by microbes in airways disease. With the application of ever more sophisticated …
role played by microbes in airways disease. With the application of ever more sophisticated …
Lung microbiota predict invasive pulmonary aspergillosis and its outcome in immunocompromised patients
Rationale Recent studies have revealed that the lung microbiota of critically ill patients is
altered and predicts clinical outcomes. The incidence of invasive fungal infections, namely …
altered and predicts clinical outcomes. The incidence of invasive fungal infections, namely …
Longitudinal profiling of the lung microbiome in the AERIS study demonstrates repeatability of bacterial and eosinophilic COPD exacerbations
Background Alterations in the composition of the lung microbiome associated with adverse
clinical outcomes, known as dysbiosis, have been implicated with disease severity and …
clinical outcomes, known as dysbiosis, have been implicated with disease severity and …
Immune mechanisms and the impact of the disrupted lung microbiome in chronic bacterial lung infection and bronchiectasis
RJ Boyton, CJ Reynolds, KJ Quigley… - Clinical & …, 2013 - academic.oup.com
Recent studies analysing immunogenetics and immune mechanisms controlling
susceptibility to chronic bacterial infection in bronchiectasis implicate dysregulated immunity …
susceptibility to chronic bacterial infection in bronchiectasis implicate dysregulated immunity …
Fluctuations in airway bacterial communities associated with clinical states and disease stages in cystic fibrosis
LA Carmody, LJ Caverly, BK Foster, MAM Rogers… - PLoS …, 2018 - journals.plos.org
Bacteria that infect the airways of persons with cystic fibrosis (CF) include a group of well-
described opportunistic pathogens as well as numerous, mainly obligate or facultative …
described opportunistic pathogens as well as numerous, mainly obligate or facultative …
Analysis of lung microbiota in bronchoalveolar lavage, protected brush and sputum samples from subjects with mild-to-moderate cystic fibrosis lung disease
DA Hogan, SD Willger, EL Dolben, TH Hampton… - PloS one, 2016 - journals.plos.org
Individuals with cystic fibrosis (CF) often acquire chronic lung infections that lead to
irreversible damage. We sought to examine regional variation in the microbial communities …
irreversible damage. We sought to examine regional variation in the microbial communities …
The respiratory microbiome in chronic hypersensitivity pneumonitis is distinct from that of idiopathic pulmonary fibrosis
R Invernizzi, BG Wu, J Barnett, P Ghai… - American journal of …, 2021 - atsjournals.org
Rationale: Chronic hypersensitivity pneumonitis (CHP) is a condition that arises after
repeated exposure and sensitization to inhaled antigens. The lung microbiome is …
repeated exposure and sensitization to inhaled antigens. The lung microbiome is …
[HTML][HTML] Impact of antibiotic treatment for pulmonary exacerbations on bacterial diversity in cystic fibrosis
BACKGROUND: A diverse array of bacterial species is present in the CF airways, in addition
to those recognised as clinically important. Here, we investigated the relative impact of …
to those recognised as clinically important. Here, we investigated the relative impact of …
Lung microbiota across age and disease stage in cystic fibrosis
B Coburn, PW Wang, J Diaz Caballero, ST Clark… - Scientific reports, 2015 - nature.com
Understanding the significance of bacterial species that colonize and persist in cystic fibrosis
(CF) airways requires a detailed examination of bacterial community structure across a …
(CF) airways requires a detailed examination of bacterial community structure across a …
Microbial epidemiology of the cystic fibrosis airways: past, present, and future
CS Thornton, MD Parkins - Seminars in Respiratory and …, 2023 - thieme-connect.com
Progressive obstructive lung disease secondary to chronic airway infection, coupled with
impaired host immunity, is the leading cause of morbidity and mortality in cystic fibrosis (CF) …
impaired host immunity, is the leading cause of morbidity and mortality in cystic fibrosis (CF) …